| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
103,000,000 |
| Market
Cap: |
215.27(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$1.15 - $9.46 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : 10.5 |
| Insider 6 Months : 10.5 |
| Insider 3/6 Months : 20.4 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Humacyte is engaged in the development and manufacture of off-the-shelf, universally implantable, bioengineered human tissues. Co. is utilizing its technology platform to develop proprietary, bioengineered, acellular human tissues for use in the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
105,993 |
105,993 |
119,731 |
236,560 |
| Total Buy Value |
$146,124 |
$146,124 |
$217,753 |
$995,499 |
| Total People Bought |
6 |
6 |
8 |
10 |
| Total Buy Transactions |
6 |
6 |
12 |
19 |
| Total Shares Sold |
0 |
0 |
5,701,083 |
18,555,382 |
| Total Sell Value |
$0 |
$0 |
$29,682,043 |
$86,204,610 |
| Total People Sold |
0 |
0 |
4 |
6 |
| Total Sell Transactions |
0 |
0 |
18 |
41 |
| End Date |
2025-03-30 |
2024-12-27 |
2024-06-28 |
2023-06-29 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Scheessele William John |
Chief Commercial Officer |
• – – |
2025-04-14 |
4 |
B |
$1.54 |
$9,999 |
D/D |
6,493 |
22,018 |
2.74 |
42% |
|
| Parikh Shamik J |
Chief Medical Officer |
• – – |
2025-04-10 |
4 |
B |
$1.55 |
$11,625 |
D/D |
7,500 |
7,500 |
2.74 |
35% |
|
| Sander Dale A. |
CFO and Chief Corp. Deve. Off. |
• – – |
2025-04-10 |
4 |
B |
$1.53 |
$30,600 |
I/I |
20,000 |
40,600 |
1.99 |
35% |
|
| Green Charles Bruce |
Director |
– • – |
2025-04-08 |
4 |
B |
$1.29 |
$7,740 |
D/D |
6,000 |
8,400 |
2.39 |
84% |
|
| Sebelius Kathleen |
Director |
– • – |
2025-04-08 |
4 |
B |
$1.32 |
$66,000 |
D/D |
50,000 |
91,207 |
2.39 |
84% |
|
| Constantino Michael T. |
Director |
– • – |
2025-04-07 |
4 |
B |
$1.26 |
$20,160 |
D/D |
16,000 |
32,950 |
2.39 |
68% |
|
| Constantino Michael T. |
Director |
– • – |
2024-12-04 |
4 |
B |
$4.39 |
$20,181 |
D/D |
4,600 |
16,950 |
2.39 |
-65% |
|
| Niklason Laura E |
President, CEO and Director |
• • – |
2024-11-20 |
4 |
S |
$4.40 |
$1,150,024 |
I/I |
(261,369) |
1,730,884 |
|
67% |
|
| Dougan Brady W |
Director |
– • – |
2024-11-20 |
4 |
S |
$4.40 |
$1,150,024 |
I/I |
(261,369) |
1,730,884 |
|
67% |
|
| Niklason Laura E |
President, CEO and Director |
• • – |
2024-11-19 |
4 |
B |
$4.44 |
$7,979 |
D/D |
1,797 |
243,851 |
2.81 |
-67% |
|
| Dougan Brady W |
Director |
– • – |
2024-11-19 |
4 |
B |
$4.44 |
$7,979 |
I/I |
1,797 |
243,851 |
2.1 |
-67% |
|
| Niklason Laura E |
President, CEO and Director |
• • – |
2024-11-19 |
4 |
S |
$4.34 |
$1,855,172 |
I/I |
(427,459) |
1,992,253 |
|
67% |
|
| Dougan Brady W |
Director |
– • – |
2024-11-19 |
4 |
S |
$4.34 |
$1,855,172 |
I/I |
(427,459) |
1,992,253 |
|
67% |
|
| Niklason Laura E |
President, CEO and Director |
• • – |
2024-11-18 |
4 |
S |
$4.44 |
$3,601,604 |
I/I |
(811,172) |
2,419,712 |
|
66% |
|
| Dougan Brady W |
Director |
– • – |
2024-11-18 |
4 |
S |
$4.44 |
$3,601,604 |
I/I |
(811,172) |
2,419,712 |
|
66% |
|
| Green Charles Bruce |
Director |
– • – |
2024-09-13 |
4 |
OE |
$4.09 |
$4,908 |
D/D |
1,200 |
2,400 |
|
- |
|
| Sebelius Kathleen |
Director |
– • – |
2024-09-10 |
4 |
S |
$5.39 |
$28,004 |
D/D |
(5,182) |
41,207 |
|
13% |
|
| Sebelius Kathleen |
Director |
– • – |
2024-09-10 |
4 |
OE |
$3.35 |
$27,926 |
D/D |
7,000 |
42,755 |
|
- |
|
| Niklason Laura E |
President, CEO and Director |
• • – |
2024-09-10 |
4 |
S |
$5.23 |
$1,509,765 |
I/I |
(288,674) |
3,230,884 |
|
13% |
|
| Dougan Brady W |
Director |
– • – |
2024-09-10 |
4 |
S |
$5.23 |
$1,509,765 |
I/I |
(288,674) |
3,230,884 |
|
13% |
|
| Niklason Laura E |
President, CEO and Director |
• • – |
2024-09-09 |
4 |
S |
$5.42 |
$854,756 |
I/I |
(157,704) |
3,519,558 |
|
18% |
|
| Dougan Brady W |
Director |
– • – |
2024-09-09 |
4 |
S |
$5.42 |
$854,756 |
I/I |
(157,704) |
3,519,558 |
|
18% |
|
| Niklason Laura E |
President, CEO and Director |
• • – |
2024-08-29 |
4 |
B |
$6.55 |
$7,998 |
D/D |
1,222 |
242,054 |
2.81 |
-24% |
|
| Dougan Brady W |
Director |
– • – |
2024-08-29 |
4 |
B |
$6.55 |
$7,998 |
I/I |
1,222 |
242,054 |
2.1 |
-24% |
|
| Niklason Laura E |
President, CEO and Director |
• • – |
2024-08-29 |
4 |
S |
$6.35 |
$2,235,911 |
I/I |
(352,112) |
3,677,262 |
|
24% |
|
133 Records found
|
|
Page 1 of 6 |
|
|
0.03 (1.42%) 
